05/24/22 Health Advisory: COVID-19 rebound after Paxlovid treatment

close up of a line of prescription pill bottles

Requested actions

  • Be aware, Centers for Disease Control and Prevention (CDC) issued a health advisory about COVID-19 rebound after Paxlovid treatment. Continue to offer Paxlovid for early-stage treatment of mild to moderate COVID-19 in people at high risk of severe disease.
  • Be aware, providers have reported COVID-19 rebound—recurring symptoms or a new positive test after a negative test—2–8 days after initial recovery. A brief return of symptoms may be part of SARS-CoV-2 infection in some people, regardless of treatment or vaccination status. Case reports suggest patients with COVID-19 rebound who were treated with Paxlovid have mild illness.

Contacting the Health Department

360-778-6100      Main Call Line – available M-F 8:30am to 4:30pm

360-715-2588      Afterhours Answering Service – available after 4:30pm and weekends

360-778-6150      Communicable Disease Report Line – 24 hours a day 7 days a week

360-778-6103      Confidential Communicable Disease Fax – 24 hours a day 7 days a week

1500 N State Street, Bellingham WA 98225

Additional information